Two Sigma Advisers’s Atossa Therapeutics ATOS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Sell |
34,200
-22,700
| -40% | -$18.8K | ﹤0.01% | 2284 |
|
|
2025
Q1 | $38.3K | Buy |
56,900
+14,500
| +34% | +$9.76K | ﹤0.01% | 2332 |
|
|
2024
Q4 | $40K | Buy |
42,400
+28,900
| +214% | +$27.3K | ﹤0.01% | 2298 |
|
|
2024
Q3 | $20.5K | Sell |
13,500
-40,700
| -75% | -$61.9K | ﹤0.01% | 2252 |
|
|
2024
Q2 | $64.5K | Buy |
54,200
+35,700
| +193% | +$42.5K | ﹤0.01% | 2347 |
|
|
2024
Q1 | $33.3K | Sell |
18,500
-6,700
| -27% | -$12.1K | ﹤0.01% | 2372 |
|
|
2023
Q4 | $22.2K | Buy |
25,200
+3,900
| +18% | +$3.43K | ﹤0.01% | 2444 |
|
|
2023
Q3 | $15.7K | Sell |
21,300
-6,100
| -22% | -$4.49K | ﹤0.01% | 2332 |
|
|
2023
Q2 | $34.5K | Sell |
27,400
-33,400
| -55% | -$42.1K | ﹤0.01% | 2296 |
|
|
2023
Q1 | $44.1K | Sell |
60,800
-30,800
| -34% | -$22.3K | ﹤0.01% | 2464 |
|
|
2022
Q4 | $48.4K | Sell |
91,600
-13,800
| -13% | -$7.29K | ﹤0.01% | 2367 |
|
|
2022
Q3 | $88K | Sell |
105,400
-21,900
| -17% | -$18.3K | ﹤0.01% | 2325 |
|
|
2022
Q2 | $139K | Sell |
127,300
-554,300
| -81% | -$605K | ﹤0.01% | 2346 |
|
|
2022
Q1 | $852K | Sell |
681,600
-916,330
| -57% | -$1.15M | ﹤0.01% | 1722 |
|
|
2021
Q4 | $2.56M | Buy |
1,597,930
+1,509,930
| +1,716% | +$2.42M | 0.01% | 1068 |
|
|
2021
Q3 | $287K | Buy |
88,000
+49,500
| +129% | +$161K | ﹤0.01% | 2132 |
|
|
2021
Q2 | $243K | Sell |
38,500
-9,900
| -20% | -$62.5K | ﹤0.01% | 2212 |
|
|
2021
Q1 | $102K | Buy |
48,400
+37,600
| +348% | +$79.2K | ﹤0.01% | 2440 |
|
|
2020
Q4 | $10K | Sell |
10,800
-1,400
| -11% | -$1.3K | ﹤0.01% | 2356 |
|
|
2020
Q3 | $30K | Buy |
+12,200
| New | +$30K | ﹤0.01% | 2349 |
|